Navigation Links
Telcyta in Medical News

Telik Presents Results at ASCO From ASSIST-5 Trial of TELCYTA in Platinum Refractory and Resistant Ovarian Cancer

PALO ALTO, Calif., May 31 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK ) today announced presentation at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Florida, of results from the ASSIST-5 Phase 3 randomized, multinational study of TELCYTA(...

Telik Announces Preclinical Presentations at AACR Annual Meeting

...iscovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Announces Fourth Quarter and 2008 Year End Financial Results and 2009 Financial Guidance

.... Telik does not undertake any obligation to update forward-looking statements contained in this press release. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. Telik, Inc. St...

Telik Announces Year-End Financial Release, Conference Call and Webcast

...overy technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...
Telcyta in Medical Technology

Telik Announces Telcyta Clinical and Preclinical Presentations at AACR Meeting

PALO ALTO, Calif., April 09, 2007 /PRNewswire-FirstCall/ -- Telik, Inc. announced that updated clinical data from its multicenter Phase 2 trial of the triplet combination of TELCYTA(R) (canfosfamide HCl, TLK286), carboplatin and paclitaxel will be presented at the 98th annual meeting of the Americ...

Telik Reports Positive Data Demonstrating Synergy in Combination and Highly Statistically Significant Effect of Telcyta as Maintenance Therapy in First-Line Non-Small Cell Lung Cancer

PALO ALTO, Calif., April 17, 2007 /PRNewswire-FirstCall/ -- Telik, Inc. announced the presentation today of results from a Phase 2 clinical trial of the triplet combination of TELCYTA(R) (canfosfamide HCl, TLK286), carboplatin and paclitaxel in the first-line treatment of advanced non-small cell l...

Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome

...very technology, TRAP((R)), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Announces Presentation at ASCO Annual Meeting

...iscovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies

...ik's results to differ materially from those indicated by these forward-looking statements, including, among others, if clinical trials of TELINTRA or telcyta are delayed or unsuccessful, Telik's business would suffer, if Telik's competitors develop and market products that are more effective than its produc...
Telcyta in Biological Technology

FDA Removes Partial Hold on TELCYTA Clinical Development

PALO ALTO, Calif., Oct. 15 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK ) announced that the U.S. Food and Drug Administration (FDA) has removed the partial hold on TELCYTA(R) (canfosfamide HCl, TLK286) clinical trials. This action follows a complete review of TELCYTA data by the agenc...

Telik Announces Second Quarter 2009 Financial Results

...king statements, including, among others, if clinical trials of TELINTRA or telcyta are delayed or unsuccessful, Telik's business would suffer, if Telik's comp...ts contained in this press release. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Reports Preclinical Results at AACR Annual Meeting

...iscovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Implements Reorganization to Focus Resources Toward Drug Development Pipeline

...iodic filings with the SEC. The Company does not undertake any obligation to update forward-looking statements. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Announces Financial Results for 2008 Third Quarter

...2008. Telik does not undertake any obligation to update forward-looking statements contained in this press release. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. Telik, Inc. Statements of Op...

Telik Announces Top-Line Results From Assist-5 Trial of Telcyta(R) in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and Resistant Ovarian Cancer

...ts from an interrupted Phase 3 randomized study of telcyta (canfosfamide HCL) in combination with pegylated l...gression-free survival (PFS) was 5.6 months on the telcyta plus PLD arm compared to 3.7 months on the PLD con...um resistant disease, including 40 patients on the telcyta plus PLD arm and 35 patients on the PLD control ar...

Telik Announces 2008 Third Quarter Financial Release, Conference Call and Webcast

...g discovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Announces Financial Results For 2008 Second Quarter

...2008. Telik does not undertake any obligation to update forward-looking statements contained in this press release. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. Telik, Inc. Statements of O...

Telik Announces 2008 Second Quarter Financial Release, Conference Call and Webcast

...g discovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Announces First Quarter 2008 Financial Results

...oking" statements, including statements regarding the future development of telcyta and TELINTRA. These forward-looking statements are based upon Telik's curre... forward-looking statements, including, among others, if clinical trials of telcyta or TELINTRA are delayed or unsuccessful, Telik's business would suffer, if ...
Other Tags
(Date:4/24/2014)... Ever since it was first identified more than ... to play an integral role in preventing the onset ... either lost or mutated, malignant cells can grow unchecked ... by investigators at Beth Israel Deaconess Medical Center (BIDMC) ... effects and how its loss or alteration can set ...
(Date:4/24/2014)... with the negative and stressful outcomes for parents who ... a life-limiting illness, says a recent study led by ... the challenges are numerous and life-changing and stress levels ... the Waterloo-led research reported positive outcomes as well, a ... the most recent issue of the American Journal ...
(Date:4/24/2014)... for BrainHealth will bring together national experts to ... at its inaugural Brain Health Summit, titled "The ... will include Dr. Sandra Bond Chapman, founder and ... Senator Chuck Grassley (R-IA), U.S. Representative Chaka Fattah ... Policy and Early Learning, U.S. Department of Education. ...
(Date:4/24/2014)... to the epidemic of prescription opioid overdose deaths was ... Medicine by leaders of agencies in the U.S. ... calls upon health care providers to expand their use ... deaths, and describes a number of misperceptions that have ... also discusses how medications can be used in combination ...
(Date:4/24/2014)... Dartmouth has been awarded one of 30 grants from ... Lead Academic Participating Site in its new National ... a select groups of investigators charged with distributing resources ... The NCTN grant system reflects recommendations from a ... to achieve four goals:, Faster design, launch, ...
Breaking Medicine News(10 mins):Health News:Surprising new insights into the PTEN tumor suppressor gene 2Health News:Surprising new insights into the PTEN tumor suppressor gene 3Health News:Parents of severely ill children see benefits as caregivers, says study 2Health News:Inaugural Brain Health Summit focuses on brain resilience and regeneration 2Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 2Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 3Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 4Health News:Dartmouth awarded lead role in NCI clinical trials network 2Health News:Dartmouth awarded lead role in NCI clinical trials network 3
(Date:4/24/2014)... Carbon offsetting initiatives could be improved with new insights ... , Scientists studying the Amazon Basin have revealed ... trees across the region by comparing satellite maps with ... enable researchers to assess more accurately the amount of ... factor in carbon offset schemes, in which trees are ...
(Date:4/23/2014)... analysis of NASA satellite data shows Africa,s Congo rainforest, ... a large-scale decline in greenness over the past decade. ... at Albany, State University of New York, shows between ... of forest area and intensified. The research, published Wednesday ... comprehensive observational studies to explore the effects of long-term ...
(Date:4/23/2014)... from the Indiana University School of Public Health-Bloomington has ... disease by finding a strong association between heme iron, ... disease. , The study found that heme iron consumption ... percent, while no association was found between nonheme iron, ... coronary heart disease. , The study was published online ...
Breaking Biology News(10 mins):Amazon rainforest survey could improve carbon offset schemes 2NASA satellites show drought may take toll on Congo rainforest 2NASA satellites show drought may take toll on Congo rainforest 3Study: Iron consumption can increase risk for heart disease 2
Other Contents